{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:24:02Z","timestamp":1793039042263,"version":"4.5.0"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41574-025-01159-z","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T09:26:03Z","timestamp":1754645163000},"page":"686-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Early-onset colorectal cancer as an emerging disease of metabolic dysregulation"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-7250","authenticated-orcid":false,"given":"Mengxi","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Drew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-9248","authenticated-orcid":false,"given":"Marcus D.","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9835-7662","authenticated-orcid":false,"given":"Yin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-6767","authenticated-orcid":false,"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"1159_CR1","unstructured":"World Health Organization. Colorectal Cancer https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer (2023)."},{"key":"1159_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1159_CR3","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","volume":"68","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 68, 2179\u20132185 (2019).","journal-title":"Gut"},{"key":"1159_CR4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum, N. & Giovannucci, E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 16, 713\u2013732 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1159_CR5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2468-1253(19)30147-5","volume":"4","author":"M Araghi","year":"2019","unstructured":"Araghi, M. et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol. Hepatol. 4, 511\u2013518 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1159_CR6","unstructured":"American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025 (ACS, 2023)."},{"key":"1159_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","volume":"26","author":"H Sung","year":"2025","unstructured":"Sung, H. et al. Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol. 26, 51\u201363 (2025).","journal-title":"Lancet Oncol."},{"key":"1159_CR8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/hex.12919","volume":"22","author":"E Blum\u2010Barnett","year":"2019","unstructured":"Blum\u2010Barnett, E. et al. Financial burden and quality of life among early\u2010onset colorectal cancer survivors: a qualitative analysis. Health Expect. 22, 1050\u20131057 (2019).","journal-title":"Health Expect."},{"key":"1159_CR9","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/cam4.4575","volume":"11","author":"AM Khoo","year":"2022","unstructured":"Khoo, A. M. et al. Understanding the psychosocial impact of colorectal cancer on young\u2010onset patients: a scoping review. Cancer Med. 11, 1688\u20131700 (2022).","journal-title":"Cancer Med."},{"key":"1159_CR10","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","volume":"138","author":"KW Jasperson","year":"2010","unstructured":"Jasperson, K. W., Tuohy, T. M., Neklason, D. W. & Burt, R. W. Hereditary and familial colon cancer. Gastroenterology 138, 2044\u20132058 (2010).","journal-title":"Gastroenterology"},{"key":"1159_CR11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMra2200869","volume":"386","author":"FA Sinicrope","year":"2022","unstructured":"Sinicrope, F. A. Increasing incidence of early-onset colorectal cancer. N. Engl. J. Med. 386, 1547\u20131558 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1159_CR12","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/jnci\/djab124","volume":"113","author":"A Cercek","year":"2021","unstructured":"Cercek, A. et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J. Natl Cancer Inst. 113, 1683\u20131692 (2021).","journal-title":"J. Natl Cancer Inst."},{"key":"1159_CR13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350\u20131356 (2015).","journal-title":"Nat. Med."},{"key":"1159_CR14","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/cncr.31994","volume":"125","author":"AN Willauer","year":"2019","unstructured":"Willauer, A. N. et al. Clinical and molecular characterization of early-onset colorectal cancer. Cancer 125, 2002\u20132010 (2019).","journal-title":"Cancer"},{"key":"1159_CR15","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233\u2013254 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"1159_CR16","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"1159_CR17","first-page":"djw322","volume":"109","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L. et al. Colorectal cancer incidence patterns in the United States, 1974\u20132013. J. Natl Cancer Inst. 109, djw322 (2017).","journal-title":"J. Natl Cancer Inst."},{"key":"1159_CR18","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jnci\/djz098","volume":"111","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Medhanie, G. A., Fedewa, S. A. & Jemal, A. State variation in early-onset colorectal cancer in the United States, 1995\u20132015. J. Natl Cancer Inst. 111, 1104\u20131106 (2019).","journal-title":"J. Natl Cancer Inst."},{"key":"1159_CR19","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-19-0899","volume":"25","author":"CH Lieu","year":"2019","unstructured":"Lieu, C. H. et al. Comprehensive genomic landscapes in early and later onset colorectal cancer. Clin. Cancer Res. 25, 5852\u20135858 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1159_CR20","doi-asserted-by":"crossref","first-page":"1349572","DOI":"10.3389\/fonc.2024.1349572","volume":"14","author":"T Lawler","year":"2024","unstructured":"Lawler, T., Parlato, L. & Warren Andersen, S. The histological and molecular characteristics of early-onset colorectal cancer: a systematic review and meta-analysis. Front. Oncol. 14, 1349572 (2024).","journal-title":"Front. Oncol."},{"key":"1159_CR21","doi-asserted-by":"crossref","unstructured":"Ogden, C. L. & Carroll, M. D. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960-62 Through 2007-2008 (NCHS, 2010).","DOI":"10.1037\/e582042012-001"},{"key":"1159_CR22","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1161\/CIRCULATIONAHA.106.613828","volume":"113","author":"CS Fox","year":"2006","unstructured":"Fox, C. S. et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s. Circulation 113, 2914\u20132918 (2006).","journal-title":"Circulation"},{"key":"1159_CR23","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.2021.16685","volume":"326","author":"A Ellison-Barnes","year":"2021","unstructured":"Ellison-Barnes, A., Johnson, S. & Gudzune, K. Trends in obesity prevalence among adults aged 18 through 25 years, 1976-2018. JAMA 326, 2073\u20132074 (2021).","journal-title":"JAMA"},{"key":"1159_CR24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","volume":"22","author":"K Flegal","year":"1998","unstructured":"Flegal, K., Carroll, M., Kuczmarski, R. & Johnson, C. Overweight and obesity in the United States: prevalence and trends, 1960\u20131994. Int. J. Obes. 22, 39\u201347 (1998).","journal-title":"Int. J. Obes."},{"key":"1159_CR25","volume":"12","author":"M Li","year":"2021","unstructured":"Li, M., Gong, W., Wang, S. & Li, Z. Trends in body mass index, overweight and obesity among adults in the USA, the NHANES from 2003 to 2018: a repeat cross-sectional survey. BMJ Open 12, e065425 (2021).","journal-title":"BMJ Open"},{"key":"1159_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajcnut.2022.10.012","volume":"117","author":"J Nielsen","year":"2023","unstructured":"Nielsen, J., Narayan, K. V. & Cunningham, S. A. Incidence of obesity across adulthood in the United States, 2001\u20132017 \u2014 a national prospective analysis. Am. J. Clin. Nutr. 117, 141\u2013148 (2023).","journal-title":"Am. J. Clin. Nutr."},{"key":"1159_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino, F. et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 13, 221\u2013262 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1159_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41574-024-01008-5","volume":"20","author":"MB Schulze","year":"2024","unstructured":"Schulze, M. B. & Stefan, N. Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications. Nat. Rev. Endocrinol. 20, 633\u2013646 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1159_CR29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ijo.2008.11","volume":"32","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral, A. et al. Accuracy of body mass index to diagnose obesity in the US adult population. Int. J. Obes. 32, 959\u2013966 (2008).","journal-title":"Int. J. Obes."},{"key":"1159_CR30","unstructured":"World Health Organization. Obesity and overweight. WHO https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight (2024)."},{"key":"1159_CR31","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jama.2014.11494","volume":"312","author":"LS Geiss","year":"2014","unstructured":"Geiss, L. S. et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA 312, 1218\u20131226 (2014).","journal-title":"JAMA"},{"key":"1159_CR32","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Overweight & obesity statistics. niddk.nih.gov https:\/\/www.niddk.nih.gov\/health-information\/health-statistics\/overweight-obesity (2021)."},{"key":"1159_CR33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S2213-8587(23)00025-6","volume":"11","author":"LE Wagenknecht","year":"2023","unstructured":"Wagenknecht, L. E. et al. Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002\u201318: results from the population-based SEARCH for Diabetes in Youth study. Lancet Diabetes Endocrinol. 11, 242\u2013250 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1159_CR34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","volume":"326","author":"JM Lawrence","year":"2021","unstructured":"Lawrence, J. M. et al. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017. JAMA 326, 717\u2013727 (2021).","journal-title":"JAMA"},{"key":"1159_CR35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/cancers15041006","volume":"15","author":"W Dong","year":"2023","unstructured":"Dong, W. et al. Geographic variation and risk factor association of early versus late onset colorectal cancer. Cancers 15, 1006 (2023).","journal-title":"Cancers"},{"key":"1159_CR36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body fatness and cancer-viewpoint of the IARC working group. N. Engl. J. Med. 375, 794\u2013798 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1159_CR37","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.14309\/ajg.0000000000001393","volume":"116","author":"H Li","year":"2021","unstructured":"Li, H., Boakye, D., Chen, X., Hoffmeister, M. & Brenner, H. Association of body mass index with risk of early-onset colorectal cancer: systematic review and meta-analysis. Am. J. Gastroenterol. 116, 2173\u20132183 (2021).","journal-title":"Am. J. Gastroenterol."},{"key":"1159_CR38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamaoncol.2018.4280","volume":"5","author":"P-H Liu","year":"2018","unstructured":"Liu, P.-H. et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol. 5, 37 (2018).","journal-title":"JAMA Oncol."},{"key":"1159_CR39","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1007\/s10620-020-06602-x","volume":"66","author":"A Elangovan","year":"2021","unstructured":"Elangovan, A. et al. Colorectal cancer, age, and obesity-related comorbidities: a large database study. Dig. Dis. Sci. 66, 3156\u20133163 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"1159_CR40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.ijo.0800561","volume":"22","author":"BJ Caan","year":"1998","unstructured":"Caan, B. J. et al. Body size and the risk of colon cancer in a large case-control study. Int. J. Obes. Relat. Metab. Disord. 22, 178\u2013184 (1998).","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"1159_CR41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jnci\/djac215","volume":"115","author":"N Murphy","year":"2023","unstructured":"Murphy, N. et al. Body mass index and molecular subtypes of colorectal cancer. J. Natl Cancer Inst. 115, 165\u2013173 (2023).","journal-title":"J. Natl Cancer Inst."},{"key":"1159_CR42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2005.09.014","volume":"42","author":"L Hou","year":"2006","unstructured":"Hou, L. et al. Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur. J. Cancer 42, 84\u201390 (2006).","journal-title":"Eur. J. Cancer"},{"key":"1159_CR43","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cgh.2018.07.030","volume":"17","author":"N Murphy","year":"2019","unstructured":"Murphy, N. et al. Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 European countries: a multinational cohort study. Clin. Gastroenterol. Hepatol. 17, 1323\u20131331.e6 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1159_CR44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.34015","volume":"151","author":"S Harlid","year":"2022","unstructured":"Harlid, S. et al. Diabetes mellitus in relation to colorectal tumor molecular subtypes: a pooled analysis of more than 9000 cases. Int. J. Cancer 151, 348\u2013360 (2022).","journal-title":"Int. J. Cancer"},{"key":"1159_CR45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gastha.2021.10.009","volume":"1","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Type 2 diabetes and risk of early-onset colorectal cancer. Gastro. Hep. Adv. 1, 186\u2013193 (2022).","journal-title":"Gastro. Hep. Adv."},{"key":"1159_CR46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.14309\/ajg.0000000000000669","volume":"115","author":"U Ali Khan","year":"2020","unstructured":"Ali Khan, U. et al. Personal history of diabetes as important as family history of colorectal cancer for risk of colorectal cancer: a nationwide cohort study. Am. J. Gastroenterol. 115, 1103\u20131109 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"1159_CR47","doi-asserted-by":"crossref","first-page":"pkab029","DOI":"10.1093\/jncics\/pkab029","volume":"5","author":"AN Archambault","year":"2021","unstructured":"Archambault, A. N. et al. Nongenetic determinants of risk for early-onset colorectal cancer. JNCI Cancer Spectr. 5, pkab029 (2021).","journal-title":"JNCI Cancer Spectr."},{"key":"1159_CR48","first-page":"241","volume":"4","author":"C Luo","year":"2024","unstructured":"Luo, C. et al. Associations between blood glucose and early- and late-onset colorectal cancer: evidence from two prospective cohorts and Mendelian randomization analyses. J. Natl Cancer Cent. 4, 241\u2013248 (2024).","journal-title":"J. Natl Cancer Cent."},{"key":"1159_CR49","volume":"8","author":"Y Ma","year":"2013","unstructured":"Ma, Y. et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS ONE\u00a08, e53916 (2013).","journal-title":"PLoS ONE"},{"key":"1159_CR50","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.3748\/wjg.v21.i19.6026","volume":"21","author":"SY Guraya","year":"2015","unstructured":"Guraya, S. Y. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review. World J. Gastroenterol. 21, 6026\u20136031 (2015).","journal-title":"World J. Gastroenterol."},{"key":"1159_CR51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-020-0329-9","volume":"16","author":"BD Hopkins","year":"2020","unstructured":"Hopkins, B. D., Goncalves, M. D. & Cantley, L. C. Insulin\u2013PI3K signalling: an evolutionarily insulated metabolic driver of cancer. Nat. Rev. Endocrinol. 16, 276\u2013283 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1159_CR52","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak, M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8, 915\u2013928 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1159_CR53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.2008.19.8937","volume":"27","author":"SS Sridhar","year":"2009","unstructured":"Sridhar, S. S. & Goodwin, P. J. Insulin-insulin-like growth factor axis and colon cancer. J. Clin. Oncol. 27, 165\u2013167 (2009).","journal-title":"J. Clin. Oncol."},{"key":"1159_CR54","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840\u2013846 (2006).","journal-title":"Nature"},{"key":"1159_CR55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman, D. A. et al. The PI3K pathway in human disease. Cell 170, 605\u2013635 (2017).","journal-title":"Cell"},{"key":"1159_CR56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4093\/dmj.2014.38.5.330","volume":"38","author":"TY Ryu","year":"2014","unstructured":"Ryu, T. Y., Park, J. & Scherer, P. E. Hyperglycemia as a risk factor for cancer progression. Diabetes Metab. J. 38, 330\u2013336 (2014).","journal-title":"Diabetes Metab. J."},{"key":"1159_CR57","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ijc.2910580325","volume":"58","author":"H Lahm","year":"1994","unstructured":"Lahm, H. et al. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int. J. Cancer 58, 452\u2013459 (1994).","journal-title":"Int. J. Cancer"},{"key":"1159_CR58","first-page":"345","volume":"9","author":"E Giovannucci","year":"2000","unstructured":"Giovannucci, E. et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomark. Prev. 9, 345\u2013349 (2000).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1159_CR59","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","volume":"91","author":"J Ma","year":"1999","unstructured":"Ma, J. et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl Cancer Inst. 91, 620\u2013625 (1999).","journal-title":"J. Natl Cancer Inst."},{"key":"1159_CR60","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-24-0115","volume":"262","author":"G Sancar","year":"2024","unstructured":"Sancar, G. & Birkenfeld, A. L. The role of adipose tissue dysfunction in hepatic insulin resistance and T2D. J. Endocrinol. 262, e240115 (2024).","journal-title":"J. Endocrinol."},{"key":"1159_CR61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm, T. V., Meier, D. T., Olefsky, J. M. & Donath, M. Y. Inflammation in obesity, diabetes, and related disorders. Immunity 55, 31\u201355 (2022).","journal-title":"Immunity"},{"key":"1159_CR62","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido, M. A. & Tena-Sempere, M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol. Metab. 35, 100937 (2020).","journal-title":"Mol. Metab."},{"key":"1159_CR63","first-page":"337","volume":"64","author":"LM Martins","year":"2020","unstructured":"Martins, L. M. et al. Type B insulin resistance syndrome: a systematic review. Arch. Endocrinol. Metab. 64, 337\u2013348 (2020).","journal-title":"Arch. Endocrinol. Metab."},{"key":"1159_CR64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85\u201397 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"1159_CR65","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","volume":"19","author":"MY Donath","year":"2019","unstructured":"Donath, M. Y., Dinarello, C. A. & Mandrup-Poulsen, T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat. Rev. Immunol. 19, 734\u2013746 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1159_CR66","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","volume":"21","author":"M Schmitt","year":"2021","unstructured":"Schmitt, M. & Greten, F. R. The inflammatory pathogenesis of colorectal cancer. Nat. Rev. Immunol. 21, 653\u2013667 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1159_CR67","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ccell.2017.11.004","volume":"32","author":"\u00d6 Canli","year":"2017","unstructured":"Canli, \u00d6. et al. Myeloid cell-derived reactive oxygen species induce epithelial mutagenesis. Cancer Cell 32, 869\u2013883.e5 (2017).","journal-title":"Cancer Cell"},{"key":"1159_CR68","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2729-3","volume":"585","author":"A Janney","year":"2020","unstructured":"Janney, A., Powrie, F. & Mann, E. H. Host-microbiota maladaptation in colorectal cancer. Nature 585, 509\u2013517 (2020).","journal-title":"Nature"},{"key":"1159_CR69","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.celrep.2018.07.085","volume":"24","author":"M Schmitt","year":"2018","unstructured":"Schmitt, M. et al. Paneth cells respond to inflammation and contribute to tissue regeneration by acquiring stem-like features through SCF\/c-kit signaling. Cell Rep. 24, 2312\u20132328.e7 (2018).","journal-title":"Cell Rep."},{"key":"1159_CR70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ceb.2016.07.010","volume":"43","author":"M Pesic","year":"2016","unstructured":"Pesic, M. & Greten, F. R. Inflammation and cancer: tissue regeneration gone awry. Curr. Opin. Cell Biol. 43, 55\u201361 (2016).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1159_CR71","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature05698","volume":"446","author":"A Nenci","year":"2007","unstructured":"Nenci, A. et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557\u2013561 (2007).","journal-title":"Nature"},{"key":"1159_CR72","doi-asserted-by":"crossref","first-page":"14007","DOI":"10.1073\/pnas.1211509109","volume":"109","author":"H Shaked","year":"2012","unstructured":"Shaked, H. et al. Chronic epithelial NF-\u03baB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc. Natl Acad. Sci. USA 109, 14007\u201314012 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR73","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","volume":"282","author":"M Visser","year":"1999","unstructured":"Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H. & Harris, T. B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131\u20132135 (1999).","journal-title":"JAMA"},{"key":"1159_CR74","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","volume":"289","author":"K Esposito","year":"2003","unstructured":"Esposito, K. et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289, 1799\u20131804 (2003).","journal-title":"JAMA"},{"key":"1159_CR75","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/oby.2009.443","volume":"18","author":"K Samaras","year":"2010","unstructured":"Samaras, K., Botelho, N. K., Chisholm, D. J. & Lord, R. V. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity 18, 884\u2013889 (2010).","journal-title":"Obesity"},{"key":"1159_CR76","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/annonc\/mdu563","volume":"26","author":"N Keum","year":"2015","unstructured":"Keum, N., Lee, D. H., Kim, R., Greenwood, D. C. & Giovannucci, E. L. Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies. Ann. Oncol. 26, 1101\u20131109 (2015).","journal-title":"Ann. Oncol."},{"key":"1159_CR77","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3389\/fimmu.2018.02918","volume":"9","author":"P Ahechu","year":"2018","unstructured":"Ahechu, P. et al. NLRP3 inflammasome: a possible link between obesity-associated low-grade chronic inflammation and colorectal cancer development. Front. Immunol. 9, 2918 (2018).","journal-title":"Front. Immunol."},{"key":"1159_CR78","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.3390\/ijms24119352","volume":"24","author":"P Gonz\u00e1lez","year":"2023","unstructured":"Gonz\u00e1lez, P., Lozano, P., Ros, G. & Solano, F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int. J. Mol. Sci. 24, 9352 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1159_CR79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41574-018-0143-9","volume":"15","author":"PD Cani","year":"2019","unstructured":"Cani, P. D. Microbiota and metabolites in metabolic diseases. Nat. Rev. Endocrinol. 15, 69\u201370 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1159_CR80","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41591-025-03693-9","volume":"31","author":"G Piccinno","year":"2025","unstructured":"Piccinno, G. et al. Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer. Nat. Med. 31, 2416\u20132429 (2025).","journal-title":"Nat. Med."},{"key":"1159_CR81","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1126\/science.aaw2367","volume":"364","author":"WS Garrett","year":"2019","unstructured":"Garrett, W. S. The gut microbiota and colon cancer. Science 364, 1133\u20131135 (2019).","journal-title":"Science"},{"key":"1159_CR82","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.3390\/ijms21186782","volume":"21","author":"L S\u00e1nchez-Alcoholado","year":"2020","unstructured":"S\u00e1nchez-Alcoholado, L. et al. Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer. Int. J. Mol. Sci. 21, 6782 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1159_CR83","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0765.2012.01498.x","volume":"48","author":"RCV Casarin","year":"2013","unstructured":"Casarin, R. C. V. et al. Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. J. Periodontal Res. 48, 30\u201336 (2013).","journal-title":"J. Periodontal Res."},{"key":"1159_CR84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195\u2013206 (2013).","journal-title":"Cell Host Microbe"},{"key":"1159_CR85","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3892\/or.2015.4398","volume":"35","author":"C Kasai","year":"2016","unstructured":"Kasai, C. et al. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: terminal restriction fragment length polymorphism and next-generation sequencing analyses. Oncol. Rep. 35, 325\u2013333 (2016).","journal-title":"Oncol. Rep."},{"key":"1159_CR86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119462","volume":"10","author":"KS Viljoen","year":"2015","unstructured":"Viljoen, K. S., Dakshinamurthy, A., Goldberg, P. & Blackburn, J. M. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS ONE\u00a010, e0119462 (2015).","journal-title":"PLoS ONE"},{"key":"1159_CR87","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","volume":"51","author":"M Gurung","year":"2020","unstructured":"Gurung, M. et al. Role of gut microbiota in type 2 diabetes pathophysiology. eBioMedicine 51, 102590 (2020).","journal-title":"eBioMedicine"},{"key":"1159_CR88","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2326-6066.CIR-13-0101","volume":"1","author":"AD Kostic","year":"2013","unstructured":"Kostic, A. D., Chun, E., Meyerson, M. & Garrett, W. S. Microbes and inflammation in colorectal cancer. Cancer Immunol. Res. 1, 150\u2013157 (2013).","journal-title":"Cancer Immunol. Res."},{"key":"1159_CR89","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 344\u2013355 (2015).","journal-title":"Immunity"},{"key":"1159_CR90","volume":"13","author":"W Ma","year":"2021","unstructured":"Ma, W. et al. Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men. Genome Med. 13, 102 (2021).","journal-title":"Genome Med."},{"key":"1159_CR91","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1016\/j.cell.2024.06.018","volume":"187","author":"E Piperni","year":"2024","unstructured":"Piperni, E. et al. Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries. Cell 187, 4554\u20134570.e18 (2024).","journal-title":"Cell"},{"key":"1159_CR92","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks, M. G. & Garrett, W. S. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341\u2013352 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1159_CR93","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jnutbio.2010.07.009","volume":"22","author":"MAR Vinolo","year":"2011","unstructured":"Vinolo, M. A. R. et al. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22, 849\u2013855 (2011).","journal-title":"J. Nutr. Biochem."},{"key":"1159_CR94","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang, P. V., Hao, L., Offermanns, S. & Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl Acad. Sci. USA 111, 2247\u20132252 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR95","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","volume":"13","author":"R Tao","year":"2007","unstructured":"Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299\u20131307 (2007).","journal-title":"Nat. Med."},{"key":"1159_CR96","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41586-020-2604-2","volume":"586","author":"S-E Wu","year":"2020","unstructured":"Wu, S.-E. et al. Microbiota-derived metabolite promotes HDAC3 activity in the gut. Nature 586, 108\u2013112 (2020).","journal-title":"Nature"},{"key":"1159_CR97","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/jcb.25955","volume":"118","author":"TT Nguyen","year":"2017","unstructured":"Nguyen, T. T. et al. Lithocholic acid stimulates IL-8 expression in human colorectal cancer cells via activation of Erk1\/2 MAPK and suppression of STAT3 activity. J. Cell Biochem. 118, 2958\u20132967 (2017).","journal-title":"J. Cell Biochem."},{"key":"1159_CR98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41574-024-01067-8","volume":"21","author":"M Cadena Sandoval","year":"2025","unstructured":"Cadena Sandoval, M. & Haeusler, R. A. Bile acid metabolism in type 2 diabetes mellitus. Nat. Rev. Endocrinol. 21, 203\u2013213 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1159_CR99","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","volume":"15","author":"TR Ahmad","year":"2019","unstructured":"Ahmad, T. R. & Haeusler, R. A. Bile acids in glucose metabolism and insulin signalling \u2014 mechanisms and research needs. Nat. Rev. Endocrinol. 15, 701\u2013712 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1159_CR100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia, W., Xie, G. & Jia, W. Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat. Rev. Gastroenterol. Hepatol. 15, 111\u2013128 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1159_CR101","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41574-022-00794-0","volume":"19","author":"M Van Hul","year":"2023","unstructured":"Van Hul, M. & Cani, P. D. The gut microbiota in obesity and weight management: microbes as friends or foe? Nat. Rev. Endocrinol. 19, 258\u2013271 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1159_CR102","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2018.09.055","volume":"175","author":"A Koh","year":"2018","unstructured":"Koh, A. et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175, 947\u2013961.e17 (2018).","journal-title":"Cell"},{"key":"1159_CR103","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nat. Commun. 12, 6757 (2021).","journal-title":"Nat. Commun."},{"key":"1159_CR104","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41586-025-09025-8","volume":"643","author":"M D\u00edaz-Gay","year":"2025","unstructured":"D\u00edaz-Gay, M. et al. Geographic and age variations in mutational processes in colorectal cancer. Nature 643, 230\u2013240 (2025).","journal-title":"Nature"},{"key":"1159_CR105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41430-022-01225-z","volume":"77","author":"AA Harb","year":"2023","unstructured":"Harb, A. A., Shechter, A., Koch, P. A. & St-Onge, M.-P. Ultra-processed foods and the development of obesity in adults. Eur. J. Clin. Nutr. 77, 619\u2013627 (2023).","journal-title":"Eur. J. Clin. Nutr."},{"key":"1159_CR106","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3945\/jn.116.242552","volume":"147","author":"F Jannasch","year":"2017","unstructured":"Jannasch, F., Kr\u00f6ger, J. & Schulze, M. B. Dietary patterns and type 2 diabetes: a systematic literature review and meta-analysis of prospective studies12. J. Nutr. 147, 1174\u20131182 (2017).","journal-title":"J. Nutr."},{"key":"1159_CR107","volume":"4","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Association between the sulfur microbial diet and risk of colorectal cancer. JAMA Netw. Open 4, e2134308 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1159_CR108","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fphys.2012.00448","volume":"3","author":"F Carbonero","year":"2012","unstructured":"Carbonero, F., Benefiel, A. C., Alizadeh-Ghamsari, A. H. & Gaskins, H. R. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front. Physiol. 3, 448 (2012).","journal-title":"Front. Physiol."},{"key":"1159_CR109","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jnci\/djaa164","volume":"113","author":"X Zheng","year":"2021","unstructured":"Zheng, X. et al. Comprehensive assessment of diet quality and risk of precursors of early-onset colorectal cancer. J. Natl Cancer Inst. 113, 543\u2013552 (2021).","journal-title":"J. Natl Cancer Inst."},{"key":"1159_CR110","doi-asserted-by":"crossref","first-page":"896330","DOI":"10.3389\/fnut.2022.896330","volume":"9","author":"KL Carroll","year":"2022","unstructured":"Carroll, K. L., Frug\u00e9, A. D., Heslin, M. J., Lipke, E. A. & Greene, M. W. Diet as a risk factor for early-onset colorectal adenoma and carcinoma: a systematic review. Front. Nutr. 9, 896330 (2022).","journal-title":"Front. Nutr."},{"key":"1159_CR111","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","volume":"57","author":"PD Cani","year":"2008","unstructured":"Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470\u20131481 (2008).","journal-title":"Diabetes"},{"key":"1159_CR112","volume":"8","author":"H Song","year":"2023","unstructured":"Song, H. et al. High-fat diet plus HNF1A variant promotes polyps by activating \u03b2-catenin in early-onset colorectal cancer. JCI Insight 8, e167163 (2023).","journal-title":"JCI Insight"},{"key":"1159_CR113","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41575-024-00893-5","volume":"21","author":"K Whelan","year":"2024","unstructured":"Whelan, K., Bancil, A. S., Lindsay, J. O. & Chassaing, B. Ultra-processed foods and food additives in gut health and disease. Nat. Rev. Gastroenterol. Hepatol. 21, 406\u2013427 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1159_CR114","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1017\/S1368980018003762","volume":"22","author":"CA Monteiro","year":"2019","unstructured":"Monteiro, C. A. et al. Ultra-processed foods: what they are and how to identify them. Public Health Nutr. 22, 936\u2013941 (2019).","journal-title":"Public Health Nutr."},{"key":"1159_CR115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ajcn\/nqab305","volume":"115","author":"F Juul","year":"2022","unstructured":"Juul, F., Parekh, N., Martinez-Steele, E., Monteiro, C. A. & Chang, V. W. Ultra-processed food consumption among US adults from 2001 to 2018. Am. J. Clin. Nutr. 115, 211\u2013221 (2022).","journal-title":"Am. J. Clin. Nutr."},{"key":"1159_CR116","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027546","volume":"9","author":"F Rauber","year":"2019","unstructured":"Rauber, F. et al. Ultra-processed foods and excessive free sugar intake in the UK: a nationally representative cross-sectional study. BMJ Open 9, e027546 (2019).","journal-title":"BMJ Open"},{"key":"1159_CR117","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cmet.2019.05.008","volume":"30","author":"KD Hall","year":"2019","unstructured":"Hall, K. D. et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of Ad libitum food intake. Cell Metab. 30, 67\u201377.e3 (2019).","journal-title":"Cell Metab."},{"key":"1159_CR118","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s13679-017-0285-4","volume":"6","author":"JM Poti","year":"2017","unstructured":"Poti, J. M., Braga, B. & Qin, B. Ultra-processed food intake and obesity: what really matters for health \u2014 processing or nutrient content? Curr. Obes. Rep. 6, 420\u2013431 (2017).","journal-title":"Curr. Obes. Rep."},{"key":"1159_CR119","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/ije\/dyab247","volume":"51","author":"FM Delpino","year":"2022","unstructured":"Delpino, F. M. et al. Ultra-processed food and risk of type 2 diabetes: a systematic review and meta-analysis of longitudinal studies. Int. J. Epidemiol. 51, 1120\u20131141 (2022).","journal-title":"Int. J. Epidemiol."},{"key":"1159_CR120","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ajcnut.2024.07.024","volume":"120","author":"M Du","year":"2024","unstructured":"Du, M. et al. Ultraprocessed food intake and body mass index change among youths: a prospective cohort study. Am. J. Clin. Nutr. 120, 836\u2013845 (2024).","journal-title":"Am. J. Clin. Nutr."},{"key":"1159_CR121","volume":"379","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Maternal consumption of ultra-processed foods and subsequent risk of offspring overweight or obesity: results from three prospective cohort studies. BMJ 379, e071767 (2022).","journal-title":"BMJ"},{"key":"1159_CR122","first-page":"S-46","volume":"169","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. 178: ultra-processed food consumption and risk of early-onset colorectal cancer precursors among women: a prospective US cohort study. Gastroenterology 169, S-46 (2025).","journal-title":"Gastroenterology"},{"key":"1159_CR123","volume":"378","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Association of ultra-processed food consumption with colorectal cancer risk among men and women: results from three prospective US cohort studies. BMJ 378, e068921 (2022).","journal-title":"BMJ"},{"key":"1159_CR124","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1136\/gutjnl-2020-323450","volume":"70","author":"J Hur","year":"2021","unstructured":"Hur, J. et al. Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women. Gut 70, 2330\u20132336 (2021).","journal-title":"Gut"},{"key":"1159_CR125","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","volume":"2","author":"J Todoric","year":"2020","unstructured":"Todoric, J. et al. Fructose stimulated de novo lipogenesis is promoted by inflammation. Nat. Metab. 2, 1034\u20131045 (2020).","journal-title":"Nat. Metab."},{"key":"1159_CR126","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/labinvest.2012.75","volume":"92","author":"A Spruss","year":"2012","unstructured":"Spruss, A., Kanuri, G., Stahl, C., Bischoff, S. C. & Bergheim, I. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab. Invest. 92, 1020\u20131032 (2012).","journal-title":"Lab. Invest."},{"key":"1159_CR127","volume":"2014","author":"R Jin","year":"2014","unstructured":"Jin, R. et al. Fructose induced endotoxemia in pediatric nonalcoholic fatty liver disease. Int. J. Hepatol. 2014, 560620 (2014).","journal-title":"Int. J. Hepatol."},{"key":"1159_CR128","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3389\/fimmu.2017.01159","volume":"8","author":"J Lambertz","year":"2017","unstructured":"Lambertz, J., Weiskirchen, S., Landert, S. & Weiskirchen, R. Fructose: a dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease. Front. Immunol. 8, 1159 (2017).","journal-title":"Front. Immunol."},{"key":"1159_CR129","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.aat8515","volume":"363","author":"MD Goncalves","year":"2019","unstructured":"Goncalves, M. D. et al. High-fructose corn syrup enhances intestinal tumor growth in mice. Science 363, 1345\u20131349 (2019).","journal-title":"Science"},{"key":"1159_CR130","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/gutjnl-2019-320438","volume":"69","author":"V Meslier","year":"2020","unstructured":"Meslier, V. et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut 69, 1258\u20131268 (2020).","journal-title":"Gut"},{"key":"1159_CR131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamainternmed.2019.2195","volume":"179","author":"F Qian","year":"2019","unstructured":"Qian, F., Liu, G., Hu, F. B., Bhupathiraju, S. N. & Sun, Q. Association between plant-based dietary patterns and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA Intern. Med. 179, 1335\u20131344 (2019).","journal-title":"JAMA Intern. Med."},{"key":"1159_CR132","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41591-023-02235-5","volume":"29","author":"P Wang","year":"2023","unstructured":"Wang, P. et al. Optimal dietary patterns for prevention of chronic disease. Nat. Med. 29, 719\u2013728 (2023).","journal-title":"Nat. Med."},{"key":"1159_CR133","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2020.03.054","volume":"159","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Risk factor profiles differ for cancers of different regions of the colorectum. Gastroenterology 159, 241\u2013256.e13 (2020).","journal-title":"Gastroenterology"},{"key":"1159_CR134","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aao5774","volume":"359","author":"L Zhao","year":"2018","unstructured":"Zhao, L. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151\u20131156 (2018).","journal-title":"Science"},{"key":"1159_CR135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki, K., Deehan, E. C., Walter, J. & B\u00e4ckhed, F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23, 705\u2013715 (2018).","journal-title":"Cell Host Microbe"},{"key":"1159_CR136","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.nutr.19.1.545","volume":"19","author":"M Lipkin","year":"1999","unstructured":"Lipkin, M., Reddy, B., Newmark, H. & Lamprecht, S. A. Dietary factors in human colorectal cancer. Annu. Rev. Nutr. 19, 545\u2013586 (1999).","journal-title":"Annu. Rev. Nutr."},{"key":"1159_CR137","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ajcn\/nqac175","volume":"116","author":"B Seethaler","year":"2022","unstructured":"Seethaler, B. et al. Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial. Am. J. Clin. Nutr. 116, 928\u2013942 (2022).","journal-title":"Am. J. Clin. Nutr."},{"key":"1159_CR138","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-01223-3","volume":"27","author":"DD Wang","year":"2021","unstructured":"Wang, D. D. et al. The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk. Nat. Med. 27, 333\u2013343 (2021).","journal-title":"Nat. Med."},{"key":"1159_CR139","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jama.2019.13771","volume":"322","author":"Z Shan","year":"2019","unstructured":"Shan, Z. et al. Trends in dietary carbohydrate, protein, and fat intake and diet quality among US adults, 1999-2016. JAMA 322, 1178\u20131187 (2019).","journal-title":"JAMA"},{"key":"1159_CR140","unstructured":"Lin, B.-H. & Guthrie, J. Over time, racial and ethnic gaps in dietary fiber consumption per 1,000 calories have widened. Economic Research Service. US Department of Agriculture https:\/\/www.ers.usda.gov\/data-products\/charts-of-note\/chart-detail?chartId=106189 (2023)."},{"key":"1159_CR141","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/ije\/dyx174","volume":"46","author":"K Aleksandrova","year":"2017","unstructured":"Aleksandrova, K. et al. Physical activity, mediating factors and risk of colon cancer: insights into adiposity and circulating biomarkers from the EPIC cohort. Int. J. Epidemiol. 46, 1823\u20131835 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"1159_CR142","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky073","volume":"2","author":"LH Nguyen","year":"2018","unstructured":"Nguyen, L. H. et al. Sedentary behaviors, TV viewing time, and risk of young-onset colorectal cancer. JNCI Cancer Spectr. 2, pky073 (2018).","journal-title":"JNCI Cancer Spectr."},{"key":"1159_CR143","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1200\/JCO.22.01895","volume":"41","author":"EH Jin","year":"2023","unstructured":"Jin, E. H. et al. Sex and tumor-site differences in the association of alcohol intake with the risk of early-onset colorectal cancer. J. Clin. Oncol. 41, 3816\u20133825 (2023).","journal-title":"J. Clin. Oncol."},{"key":"1159_CR144","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ajcn\/70.5.928","volume":"70","author":"SQ Siler","year":"1999","unstructured":"Siler, S. Q., Neese, R. A. & Hellerstein, M. K. De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. Am. J. Clin. Nutr. 70, 928\u2013936 (1999).","journal-title":"Am. J. Clin. Nutr."},{"key":"1159_CR145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.alcohol.2020.11.001","volume":"90","author":"MM Syed-Abdul","year":"2021","unstructured":"Syed-Abdul, M. M. et al. The tailgate study: differing metabolic effects of a bout of excessive eating and drinking. Alcohol 90, 45\u201355 (2021).","journal-title":"Alcohol"},{"key":"1159_CR146","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199204093261503","volume":"326","author":"PM Suter","year":"1992","unstructured":"Suter, P. M., Schutz, Y. & Jequier, E. The effect of ethanol on fat storage in healthy subjects. N. Engl. J. Med. 326, 983\u2013987 (1992).","journal-title":"N. Engl. J. Med."},{"key":"1159_CR147","first-page":"672","volume":"67","author":"Y Cao","year":"2018","unstructured":"Cao, Y. et al. Long-term use of antibiotics and risk of colorectal adenoma. Gut 67, 672\u2013678 (2018).","journal-title":"Gut"},{"key":"1159_CR148","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1136\/gutjnl-2019-318593","volume":"68","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study. Gut 68, 1971\u20131978 (2019).","journal-title":"Gut"},{"key":"1159_CR149","volume":"13","author":"LH Nguyen","year":"2022","unstructured":"Nguyen, L. H. et al. Antibiotic therapy and risk of early-onset colorectal cancer: a national case-control study. Clin. Transl. Gastroenterol. 13, e00437 (2022).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"1159_CR150","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.cgh.2024.09.002","volume":"23","author":"KJ Kane","year":"2025","unstructured":"Kane, K. J. et al. Oral antibiotic use in adulthood and risk of early-onset colorectal cancer: a case-control study. Clin. Gastroenterol. Hepatol. 23, 1440\u20131447.e5 (2025).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1159_CR151","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.2021.6238","volume":"325","author":"US Preventive Services Task Force.","year":"2021","unstructured":"US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 325, 1965\u20131977 (2021).","journal-title":"JAMA"},{"key":"1159_CR152","first-page":"250","volume":"68","author":"AMD Wolf","year":"2018","unstructured":"Wolf, A. M. D. et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J. Clin. 68, 250\u2013281 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"1159_CR153","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ajg.2017.174","volume":"112","author":"DK Rex","year":"2017","unstructured":"Rex, D. K. et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am. J. Gastroenterol. 112, 1016\u20131030 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"1159_CR154","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1940-6207.CAPR-22-0305","volume":"15","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. Endoscopic screening and risk of colorectal cancer according to type 2 diabetes status. Cancer Prev. Res. 15, 847\u2013856 (2022).","journal-title":"Cancer Prev. Res."},{"key":"1159_CR155","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1053\/j.gastro.2018.02.021","volume":"154","author":"J Jeon","year":"2018","unstructured":"Jeon, J. et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology 154, 2152\u20132164.e19 (2018).","journal-title":"Gastroenterology"},{"key":"1159_CR156","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/jgh.15171","volume":"36","author":"JQ Liang","year":"2021","unstructured":"Liang, J. Q. et al. Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects. J. Gastroenterol. Hepatol. 36, 1035\u20131043 (2021).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1159_CR157","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/gutjnl-2019-318532","volume":"69","author":"JQ Liang","year":"2020","unstructured":"Liang, J. Q. et al. A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer. Gut 69, 1248\u20131257 (2020).","journal-title":"Gut"},{"key":"1159_CR158","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","volume":"63","author":"MD Jensen","year":"2014","unstructured":"Jensen, M. D. et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J. Am. Coll. Cardiol. 63, 2985\u20133023 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1159_CR159","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2017.01.045","volume":"152","author":"VL Webb","year":"2017","unstructured":"Webb, V. L. & Wadden, T. A. Intensive lifestyle intervention for obesity: principles, practices, and results. Gastroenterology 152, 1752\u20131764 (2017).","journal-title":"Gastroenterology"},{"key":"1159_CR160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1377\/hlthaff.2011.1009","volume":"31","author":"MK Ali","year":"2012","unstructured":"Ali, M. K., Echouffo-Tcheugui, J. & Williamson, D. F. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Aff. 31, 67\u201375 (2012).","journal-title":"Health Aff."},{"key":"1159_CR161","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/jama.2010.1503","volume":"304","author":"CL Rock","year":"2010","unstructured":"Rock, C. L. et al. Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women: a randomized controlled trial. JAMA 304, 1803\u20131810 (2010).","journal-title":"JAMA"},{"key":"1159_CR162","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(11)61344-5","volume":"378","author":"SA Jebb","year":"2011","unstructured":"Jebb, S. A. et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 378, 1485\u20131492 (2011).","journal-title":"Lancet"},{"key":"1159_CR163","doi-asserted-by":"crossref","first-page":"d6500","DOI":"10.1136\/bmj.d6500","volume":"343","author":"K Jolly","year":"2011","unstructured":"Jolly, K. et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten up randomised controlled trial. BMJ 343, d6500 (2011).","journal-title":"BMJ"},{"key":"1159_CR164","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/oby.2007.614","volume":"15","author":"CL Rock","year":"2007","unstructured":"Rock, C. L., Pakiz, B., Flatt, S. W. & Quintana, E. L. Randomized trial of a multifaceted commercial weight loss program. Obesity 15, 939\u2013949 (2007).","journal-title":"Obesity"},{"key":"1159_CR165","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41591-020-0934-0","volume":"26","author":"SE Berry","year":"2020","unstructured":"Berry, S. E. et al. Human postprandial responses to food and potential for precision nutrition. Nat. Med. 26, 964\u2013973 (2020).","journal-title":"Nat. Med."},{"key":"1159_CR166","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s42255-021-00383-x","volume":"3","author":"P Wyatt","year":"2021","unstructured":"Wyatt, P. et al. Postprandial glycaemic dips predict appetite and energy intake in healthy individuals. Nat. Metab. 3, 523\u2013529 (2021).","journal-title":"Nat. Metab."},{"key":"1159_CR167","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41591-020-01183-8","volume":"27","author":"F Asnicar","year":"2021","unstructured":"Asnicar, F. et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat. Med. 27, 321\u2013332 (2021).","journal-title":"Nat. Med."},{"key":"1159_CR168","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/s41591-024-02951-6","volume":"30","author":"KM Bermingham","year":"2024","unstructured":"Bermingham, K. M. et al. Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial. Nat. Med. 30, 1888\u20131897 (2024).","journal-title":"Nat. Med."},{"key":"1159_CR169","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamaoncol.2023.5573","volume":"10","author":"L Wang","year":"2024","unstructured":"Wang, L., Wang, W., Kaelber, D. C., Xu, R. & Berger, N. A. GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight\/obesity. JAMA Oncol. 10, 256\u2013258 (2024).","journal-title":"JAMA Oncol."},{"key":"1159_CR170","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(15)00565-3","volume":"17","author":"T Higurashi","year":"2016","unstructured":"Higurashi, T. et al. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial. Lancet Oncol. 17, 475\u2013483 (2016).","journal-title":"Lancet Oncol."},{"key":"1159_CR171","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1940-6207.CAPR-18-0262","volume":"13","author":"JA Zell","year":"2020","unstructured":"Zell, J. A. et al. A phase IIa trial of metformin for colorectal cancer risk reduction among individuals with history of colorectal adenomas and elevated body mass index. Cancer Prev. Res. 13, 203\u2013212 (2020).","journal-title":"Cancer Prev. Res."},{"key":"1159_CR172","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjmed.2007.09.016","volume":"121","author":"SR Salpeter","year":"2008","unstructured":"Salpeter, S. R., Buckley, N. S., Kahn, J. A. & Salpeter, E. E. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am. J. Med. 121, 149\u2013157.e2 (2008).","journal-title":"Am. J. Med."},{"key":"1159_CR173","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff, A. M. et al. Tirzepatide once weekly for the treatment of obesity. N. Engl. J. Med. 387, 205\u2013216 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1159_CR174","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-med-060319-120913","volume":"72","author":"DA Drew","year":"2021","unstructured":"Drew, D. A. & Chan, A. T. Aspirin in the prevention of colorectal neoplasia. Annu. Rev. Med. 72, 415\u2013430 (2021).","journal-title":"Annu. Rev. Med."},{"key":"1159_CR175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/j.gastro.2020.01.004","volume":"159","author":"EE Low","year":"2020","unstructured":"Low, E. E. et al. Risk factors for early-onset colorectal cancer. Gastroenterology 159, 492\u2013501.e7 (2020).","journal-title":"Gastroenterology"},{"key":"1159_CR176","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41574-021-00627-6","volume":"18","author":"VS Malik","year":"2022","unstructured":"Malik, V. S. & Hu, F. B. The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases. Nat. Rev. Endocrinol. 18, 205\u2013218 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1159_CR177","volume":"4","author":"M Du","year":"2020","unstructured":"Du, M. et al. Cost-effectiveness of a national sugar-sweetened beverage tax to reduce cancer burdens and disparities in the United States. JNCI Cancer Spectr. 4, pkaa073 (2020).","journal-title":"JNCI Cancer Spectr."},{"key":"1159_CR178","volume":"5","author":"T Andreyeva","year":"2022","unstructured":"Andreyeva, T., Marple, K., Marinello, S., Moore, T. E. & Powell, L. M. Outcomes following taxation of sugar-sweetened beverages: a systematic review and meta-analysis. JAMA Netw. Open 5, e2215276 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1159_CR179","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/obr.12868","volume":"20","author":"AM Teng","year":"2019","unstructured":"Teng, A. M. et al. Impact of sugar-sweetened beverage taxes on purchases and dietary intake: systematic review and meta-analysis. Obes. Rev. 20, 1187\u20131204 (2019).","journal-title":"Obes. Rev."},{"key":"1159_CR180","unstructured":"U.S. Food and Drugs Administration. FDA issues proposed rule on front-of-package nutrition labeling. FDA https:\/\/www.fda.gov\/food\/hfp-constituent-updates\/fda-issues-proposed-rule-front-package-nutrition-labeling (2025)."},{"key":"1159_CR181","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.amepre.2018.09.024","volume":"56","author":"S Shangguan","year":"2019","unstructured":"Shangguan, S. et al. A meta-analysis of food labeling effects on consumer diet behaviors and industry practices. Am. J. Prev. Med. 56, 300\u2013314 (2019).","journal-title":"Am. J. Prev. Med."},{"key":"1159_CR182","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc13-1203","volume":"37","author":"M Ding","year":"2014","unstructured":"Ding, M., Bhupathiraju, S. N., Chen, M., van Dam, R. M. & Hu, F. B. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 37, 569\u2013586 (2014).","journal-title":"Diabetes Care"},{"key":"1159_CR183","volume":"387","author":"B Liu","year":"2024","unstructured":"Liu, B. et al. Chocolate intake and risk of type 2 diabetes: prospective cohort studies. BMJ 387, e078386 (2024).","journal-title":"BMJ"},{"key":"1159_CR184","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/10408398.2018.1507996","volume":"59","author":"R Tabrizi","year":"2019","unstructured":"Tabrizi, R. et al. The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials. Crit. Rev. Food Sci. Nutr. 59, 2688\u20132696 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"1159_CR185","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1056\/NEJMoa1014296","volume":"364","author":"D Mozaffarian","year":"2011","unstructured":"Mozaffarian, D., Hao, T., Rimm, E. B., Willett, W. C. & Hu, F. B. Changes in diet and lifestyle and long-term weight gain in women and men. N. Engl. J. Med. 364, 2392\u20132404 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1159_CR186","doi-asserted-by":"crossref","first-page":"146S","DOI":"10.3945\/an.115.011536","volume":"8","author":"C Sayon-Orea","year":"2017","unstructured":"Sayon-Orea, C., Mart\u00ednez-Gonz\u00e1lez, M. A., Ruiz-Canela, M. & Bes-Rastrollo, M. Associations between yogurt consumption and weight gain and risk of obesity and metabolic syndrome: a systematic review. Adv. Nutr. 8, 146S\u2013154S (2017).","journal-title":"Adv. Nutr."},{"key":"1159_CR187","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ijo.2015.202","volume":"40","author":"J Eales","year":"2016","unstructured":"Eales, J. et al. Is consuming yoghurt associated with weight management outcomes? Results from a systematic review. Int. J. Obes. 40, 731\u2013746 (2016).","journal-title":"Int. J. Obes."},{"key":"1159_CR188","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/advances\/nmy107","volume":"10","author":"C Alvarez-Bueno","year":"2019","unstructured":"Alvarez-Bueno, C. et al. Effects of milk and dairy product consumption on type 2 diabetes: overview of systematic reviews and meta-analyses. Adv. Nutr. 10, S154\u2013S163 (2019).","journal-title":"Adv. Nutr."},{"key":"1159_CR189","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2452237","volume":"17","author":"S Ugai","year":"2025","unstructured":"Ugai, S. et al. Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor. Gut Microbes 17, 2452237 (2025).","journal-title":"Gut Microbes"},{"key":"1159_CR190","volume":"67","author":"CY Um","year":"2020","unstructured":"Um, C. Y. et al. Coffee consumption and risk of colorectal cancer in the Cancer Prevention Study-II nutrition cohort. Cancer Epidemiol. 67, 101730 (2020).","journal-title":"Cancer Epidemiol."},{"key":"1159_CR191","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/1055-9965.EPI-15-0924","volume":"25","author":"SL Schmit","year":"2016","unstructured":"Schmit, S. L., Rennert, H. S., Rennert, G. & Gruber, S. B. Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol. Biomark. Prev. 25, 634\u2013639 (2016).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1159_CR192","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35935","volume":"10","author":"A AlZaabi","year":"2024","unstructured":"AlZaabi, A., Younus, H. A., Al-Reasi, H. A. & Al-Hajri, R. Could environmental exposure and climate change be a key factor in the rising incidence of early onset colorectal cancer? Heliyon 10, e35935 (2024).","journal-title":"Heliyon"},{"key":"1159_CR193","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.3748\/wjg.v22.i13.3611","volume":"22","author":"JY Kim","year":"2016","unstructured":"Kim, J. Y. et al. Different risk factors for advanced colorectal neoplasm in young adults. World J. Gastroenterol. 22, 3611\u20133620 (2016).","journal-title":"World J. Gastroenterol."},{"key":"1159_CR194","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/gutjnl-2014-309007","volume":"65","author":"ED Kantor","year":"2016","unstructured":"Kantor, E. D. et al. Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk. Gut 65, 1289\u20131295 (2016).","journal-title":"Gut"},{"key":"1159_CR195","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/cncr.30819","volume":"123","author":"Z Levi","year":"2017","unstructured":"Levi, Z. et al. Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: a population-based study. Cancer 123, 4022\u20134030 (2017).","journal-title":"Cancer"},{"key":"1159_CR196","first-page":"291","volume":"31","author":"C Dash","year":"2020","unstructured":"Dash, C. et al. Obesity is an initiator of colon adenomas but not a promoter of colorectal cancer in the Black Women\u2019s Health Study. Cancer Causes Control. 31, 291\u2013302 (2020).","journal-title":"Cancer Causes Control."},{"key":"1159_CR197","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2022.05.032","volume":"163","author":"EH Jin","year":"2022","unstructured":"Jin, E. H. et al. Association between metabolic syndrome and the risk of colorectal cancer diagnosed before age 50 years according to tumor location. Gastroenterology 163, 637\u2013648.e2 (2022).","journal-title":"Gastroenterology"},{"key":"1159_CR198","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.annonc.2021.03.200","volume":"32","author":"Y Yue","year":"2021","unstructured":"Yue, Y. et al. Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women. Ann. Oncol. 32, 778\u2013786 (2021).","journal-title":"Ann. Oncol."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01159-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:03:32Z","timestamp":1760054612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01159-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":198,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1038\/s41574-025-01159-z","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"15 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.D.G. holds equity in Faeth Therapeutics and Skye Biosciences; reports consulting or advisory roles with Almac Discovery, Genentech Inc., Faeth Therapeutics, Scorpion Therapeutics and Skye Biosciences; and patents, royalties and other intellectual property with Weill Cornell Medicine and Faeth Therapeutics. Y.C. has served as a consultant for Need Inc. and Geneocopy Inc. A.T.C. serves as a consultant for Pfizer Inc. and Boehringer Ingelheim. All of the above disclosures are outside of the submitted work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}